Patrick Donnelly

Board Member

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group, and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

October 15, 2019
Just How Mature Is Your Data Lifecycle / Data Management…
How do you know whether your data governance activities have matured to the degree… Read More
October 14, 2019
Meet the Experts: Marc Stegeman and Jan Zorgdrager
Learn how Marc and Jan are working to globally support ProPharma Group's… Read More
September 23, 2019
Meet the Expert: Robert Kuntz
Meet Robert Kuntz, a Managing Consultant helping clients transform ideas into reality as part… Read More
More Articles

UPCOMING Events

October 27, 2019
2019 ISPE Annual Meeting & Expo
The 2019 ISPE Annual Meeting & Expo will focus on excellence, modernization, and harmonization in pharmace... Read More
October 29, 2019
Clinical Trials: The Bridge to an Optimal Registration
Join ProPharma Group for our seminar on Clinical Trials: The Bridge to an Optimal Registration!  Will your cl... Read More
October 30, 2019
5th Pharmacovigilance & Drug Safety Summit
This two-day event will bring together top professionals working on the latest trends to be both proactive and... Read More
All Events
Contact Us